Towards New Standards In Type 1 Diabetes Management (S1/#1)

-









Insulin remains a cornerstone for diabetes management around the world. A century of years ago, diagnosis with type 1 diabetes would mean a death sentence to the one afflicted & woeful to the family at large.

The unique challenges of T1D in children & Adolescents, for both individuals & their caregivers, and clinicians:

HbA1c (a haemoglobin to which glucose is bound) and rate of hypoglycemia is declining with modern therapy but remains above the target in all age, despite the increased use of insulin pumps and CGMs (Continuous Glucose Monitoring).
Moreover, on the subject of (DKA) Diabetic Ketoacidosis – (a complex metabolic disorder that occurs when the liver starts breaking down fat at an excessive rate producing ketones, which can cause the blood to become dangerously acidic), a therapy to suppress the condition was introduced such as: Blood ketone monitoring & education programs but still DKA remains a challenge on a worldwide scale. The issues leading to DKA are actually associated with: Eating disorders, ethnic minorities & HbA1c above target.

Above all, the big issue is that some patients get used to a certain HbA1c and then becomes very difficult to increase and intensify their therapy to get them back on track to have a more aggressive approach to a glycaemic control. Additionally, fear of hypoglycemia remains one of the biggest obstacles in terms of reaching glycaemic goals. Thus, this may lead to under-insulinization and again increasing the risk of DKA, thus the challenge on glycaemic control in pediatric populations.

Recommendations are:



Intensive insulin therapy that allows more flexibility in dosing time could help reduce long-term complications in children and adolescents with Type 1 Diabetes (T1D) would be able to improve their controls.
NB. There are a range of glycaemic targets for children with diabetes depending on their risk of awareness of hypoglycemia.
Targeted DKA prevention programs could result in substantial healthcare cost reduction and reduced patient morbidity & mortality.
To counteract against such delicate behaviors and process, governments and medicine manufacturers have to ensure constant insulin deliveries.

Second-generation basal insulin analogs: in Children & Adolescents?

1. Gla-300 (glargine-300) has demonstrated similar glycaemic efficacy compared with Gla-100 in children & adolescents aged 6-17 years with Type 1 Diabetes (T1D);
2. Comparable overall hypoglycemic incidence and rates were also demonstrated with Gla-300 compared with Gla-100;
3. In the study in adolescents & children, the percentage (%) of the individuals reporting severe hypoglycaemia was lower in patients using Gla-300 compared with patients using Gla-100. The percentage of patients with hypoglycaemic episodes with ketosis was lower with Gla-300 compared with Gla-100.
4. Tresiba (INN-insulin degludec) is indicated for treatment of diabetes mellitus in adults, adolescents and children from the age of 1 year.

Towards Modernizing Diabetes Care Using New Metrics
Towards Improving Diabetes Care 

Curtsy of Professor Thomas Danne 

#UniteForDiabetes
#insulin4all
#dedoc Voice


Comments

Post a Comment

Popular posts from this blog

From Diagnosis to Determination: Rejoice's Journey with Type 1 Diabetes

-
Image
  Rejoice Tsingano I can still vividly remember the pivotal moment in 2018 when I stood in front of the mirror and noticed something startling: my school uniform no longer fit as it once did. "Wait a second, did I just lose some weight?" I asked myself, drawing closer to the mirror to confirm. To my surprise and delight, I had indeed shed a few pounds—a goal I had long aspired to achieve. Little did I know that this unexpected weight loss was a signal of something far more serious. My name is Rejoice Tsingano, and I was diagnosed with type 1 diabetes on August 8, 2018. But let me take you back a bit further. Two months before my diagnosis, I began to notice the first symptoms: rapid weight loss and a dramatic change in my complexion, which had become so light that people around me speculated I might be bleaching my skin. All of this unfolded while I was attending boarding school in Zvishavane during vacation lessons, preparing for my final O-level exams. Had I been at home, p...
Read more

Empowering Lives: A Transformative Diabetes Camp in Zimbabwe

-
Image
  In an unparalleled event aimed at tackling the growing challenges faced by individuals living with type 1 diabetes in Zimbabwe, a transformative camp was held, bringing together over 100 people living with type 1 diabetes (T1D) and more than 20 parents and guardians. This gathering was not just a camp but a beacon of hope, education, and community for those who have long been navigating the complexities of life with T1D in a landscape that often feels isolating and overwhelming. Setting the Stage: A Wake-Up Call The camp began with a keynote address that vividly exposed the stark and pressing realities of diabetes care in Zimbabwe. This address was more than just an opening—it was a call to action, emphasizing the urgent need to tackle the multifaceted challenges that people living with Type 1 diabetes face daily. The address brought to light critical issues such as pervasive discrimination, chronic shortages of insulin, inadequate diabetes education, and the desperate need for c...
Read more

Breaking Barriers: fighting for our daughter's disability rights in U.S. Schools

-
Image
Coral, T1D since 03/16 Welcome to our guest blog, where we have the honor of featuring the insightful perspective of Shelsea Deng , a dedicated advocate for children with chronic conditions. In this compelling piece, Shelsea shares her journey advocating for her daughter, Coral, who was diagnosed with autoimmune Type 1 diabetes at a very young age. Through her experiences, Shelsea sheds light on the challenges faced by families dealing with chronic conditions in the education system. Shelsea, Coral & Kaila In your experience, how has stigma and discrimination affected your child's education and daily life? My first-born daughter, Coral, was diagnosed with autoimmune Type 1 diabetes at 15 months old on March 11, 2016, back home in Oahu, HI. Type 1 diabetes is very rare among Asians and even rarer in Native Hawaiians (we are part of the "AANHPI" community and also part Native American). Consequently, I have often been confronted with a barrage of questions and misconcep...
Read more